{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:06:35Z","timestamp":1773378395775,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejso.2025.110258","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T02:39:02Z","timestamp":1750473542000},"page":"110258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysis"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9684-8918","authenticated-orcid":false,"given":"Vanja","family":"Podrascanin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-0588","authenticated-orcid":false,"given":"Markus","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-2769","authenticated-orcid":false,"given":"Hallbera","family":"Gudmundsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-7043","authenticated-orcid":false,"given":"Zhihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-8601","authenticated-orcid":false,"given":"Cornelius A.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne G.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7960-3254","authenticated-orcid":false,"given":"Michael L.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory L.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"Starlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110258_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2025.110258_bib2","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2025.110258_bib3","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201cCarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","article-title":"Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival","volume":"140","author":"Givi","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110258_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/973946","article-title":"Surgical treatment of neuroendocrine liver metastases","volume":"2012","author":"Lee","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.ejso.2025.110258_bib6","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","article-title":"Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis","volume":"17","author":"Mayo","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: : a plea for resection to increase survival","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2025.110258_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.surg.2014.08.009","article-title":"Expanded criteria for carcinoid liver debulking: maintaining survival and increasing the number of eligible patients","volume":"156","author":"Graff-Baker","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110258_bib9","series-title":"Surveillance, epidemiology, and End Results (SEER) program","year":"2022"},{"key":"10.1016\/j.ejso.2025.110258_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.6004\/jnccn.2020.7666","article-title":"Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: a population-based analysis","volume":"19","author":"Hallet","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2025.110258_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MPA.0000000000001723","article-title":"Causes of death after neuroendocrine tumors diagnosis: a US population-based analysis","volume":"50","author":"Sonbol","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.ejso.2025.110258_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ejso.2025.110258_bib13","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1245\/s10434-024-15374-x","article-title":"Neuroendocrine tumors of unknown primary in the setting of cytoreductive hepatectomy","volume":"31","author":"Ammann","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12957-019-1597-5","article-title":"Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma","volume":"17","author":"Feng","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib15","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1245\/s10434-020-08510-w","article-title":"Midgut neuroendocrine tumors with liver-only metastases: benefit of primary tumor resection","volume":"27","author":"Gangi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","article-title":"Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system","volume":"12","author":"Strasberg","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ejso.2025.110258_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.110258_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110258_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","article-title":"Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)","volume":"13","author":"Rahbari","year":"2011","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2025.110258_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study group of liver surgery","volume":"149","author":"Koch","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110258_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2020.03.030","article-title":"Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors","volume":"169","author":"Wonn","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2025.110258_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Shah","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2025.110258_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/his.15025","article-title":"Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: a systematic review and meta\u2010analysis","volume":"84","author":"Mestre\u2010Alagarda","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2025.110258_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109678","article-title":"Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: a single center retrospective analysis","volume":"51","author":"Ammann","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib25","first-page":"582","article-title":"Management of well-differentiated neuroendocrine tumors","volume":"19","author":"Tella","year":"2021","journal-title":"Clin Adv Hematol Oncol HO"},{"key":"10.1016\/j.ejso.2025.110258_bib26","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1245\/s10434-023-13372-z","article-title":"Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term Follow-up evaluation of more than 500 patients","volume":"30","author":"Gudmundsdottir","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110258_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/theoncologist.2016-0175","article-title":"Association between tumor progression endpoints and overall survival in patients with advanced neuroendocrine tumors","volume":"22","author":"Ter-Minassian","year":"2017","journal-title":"Oncologist"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325006869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325006869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T01:47:43Z","timestamp":1757036863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325006869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0748798325006869"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110258","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110258"}}